Cargando…
Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study)
BACKGROUND: Knowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850604/ https://www.ncbi.nlm.nih.gov/pubmed/30779208 http://dx.doi.org/10.1111/pace.13636 |
_version_ | 1783469460452016128 |
---|---|
author | Broers, Eva R. Lodder, Paul Spek, Viola R.M. Widdershoven, Jos W.M.G. Pedersen, Susanne S. Habibović, Mirela |
author_facet | Broers, Eva R. Lodder, Paul Spek, Viola R.M. Widdershoven, Jos W.M.G. Pedersen, Susanne S. Habibović, Mirela |
author_sort | Broers, Eva R. |
collection | PubMed |
description | BACKGROUND: Knowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective study design. METHODS: ICD patients (N = 201) completed a set of questionnaires at baseline and 3, 6, and 12 months after inclusion. A hierarchical multiple linear regression with three models was performed to examine predictors of HCU. RESULTS: HCU was highest between baseline and 3 months postimplantation and gradually decreased during 12 months follow‐up. During the first year postimplantation, only depression (β = 0.342, P = 0.002) was a significant predictor. Between baseline and 3 months follow‐up, younger age (β = −0.220, P < 0.01), New York Heart Association class III/IV (β = 0.705, P = 0.01), and secondary indication (β = 0.148, P = 0.05) were independent predictors for increased HCU. Between 3 and 6 months follow‐up, younger age (β = −0.151, P = 0.05) and depression (β = 0.370, P < 0.001) predicted increased HCU. Between 6 and 12 months only depression (β = 0.355, P = 0.001) remained a significant predictor. CONCLUSIONS: Depression was an important predictor of increased HCU in ICD patients in the first year postimplantation, particularly after 3 months postimplantation. Identifying patients who need additional care and provide this on time might better meet patients’ needs and lower future HCU. |
format | Online Article Text |
id | pubmed-6850604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68506042019-11-18 Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study) Broers, Eva R. Lodder, Paul Spek, Viola R.M. Widdershoven, Jos W.M.G. Pedersen, Susanne S. Habibović, Mirela Pacing Clin Electrophysiol Devices BACKGROUND: Knowledge of the level of healthcare utilization (HCU) and the predictors of high HCU use in patients with an implantable cardioverter defibrillator (ICD) is lacking. We examined the level of HCU and predictors associated with increased HCU in first‐time ICD patients, using a prospective study design. METHODS: ICD patients (N = 201) completed a set of questionnaires at baseline and 3, 6, and 12 months after inclusion. A hierarchical multiple linear regression with three models was performed to examine predictors of HCU. RESULTS: HCU was highest between baseline and 3 months postimplantation and gradually decreased during 12 months follow‐up. During the first year postimplantation, only depression (β = 0.342, P = 0.002) was a significant predictor. Between baseline and 3 months follow‐up, younger age (β = −0.220, P < 0.01), New York Heart Association class III/IV (β = 0.705, P = 0.01), and secondary indication (β = 0.148, P = 0.05) were independent predictors for increased HCU. Between 3 and 6 months follow‐up, younger age (β = −0.151, P = 0.05) and depression (β = 0.370, P < 0.001) predicted increased HCU. Between 6 and 12 months only depression (β = 0.355, P = 0.001) remained a significant predictor. CONCLUSIONS: Depression was an important predictor of increased HCU in ICD patients in the first year postimplantation, particularly after 3 months postimplantation. Identifying patients who need additional care and provide this on time might better meet patients’ needs and lower future HCU. John Wiley and Sons Inc. 2019-03-05 2019-04 /pmc/articles/PMC6850604/ /pubmed/30779208 http://dx.doi.org/10.1111/pace.13636 Text en © 2019 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Devices Broers, Eva R. Lodder, Paul Spek, Viola R.M. Widdershoven, Jos W.M.G. Pedersen, Susanne S. Habibović, Mirela Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study) |
title | Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study) |
title_full | Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study) |
title_fullStr | Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study) |
title_full_unstemmed | Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study) |
title_short | Healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the WEBCARE study) |
title_sort | healthcare utilization in patients with first‐time implantable cardioverter defibrillators (data from the webcare study) |
topic | Devices |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850604/ https://www.ncbi.nlm.nih.gov/pubmed/30779208 http://dx.doi.org/10.1111/pace.13636 |
work_keys_str_mv | AT broersevar healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy AT lodderpaul healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy AT spekviolarm healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy AT widdershovenjoswmg healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy AT pedersensusannes healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy AT habibovicmirela healthcareutilizationinpatientswithfirsttimeimplantablecardioverterdefibrillatorsdatafromthewebcarestudy |